Tag: Gilead Sciences Inc

Sickle cell gene therapies offer new hope, but access remains a major challenge

Posted on By Admin No Comments on Sickle cell gene therapies offer new hope, but access remains a major challenge

This microscope photo provided on Oct. 25, 2023, by the Centers for Disease Control and Prevention shows crescent-shaped red blood cells from a sickle cell disease patient in 1972. Britain’s medicines regulator has authorized the world’s first gene therapy treatment for sickle cell disease, in a move that could offer relief to thousands of people…

Read More “Sickle cell gene therapies offer new hope, but access remains a major challenge” »

Health

A rare disease is taking his vision. A gene therapy could help — if he can get it

Posted on By Admin No Comments on A rare disease is taking his vision. A gene therapy could help — if he can get it

Judy and Courtney Stecker with their sons, Read (left) and Wheeler (right). Judy and Courtney Stecker CNBC Cures is proudly underwritten by Alexion, AstraZeneca Rare Disease, whose support enables our journalism to elevate stories that advance research, innovation and patient care in rare diseases. If any parents should be able to help their sick child,…

Read More “A rare disease is taking his vision. A gene therapy could help — if he can get it” »

Health

FDA approves daily HIV pill from Gilead designed to simplify treatment for some patients

Posted on By Admin No Comments on FDA approves daily HIV pill from Gilead designed to simplify treatment for some patients

The Food and Drug Administration approved a once-daily HIV pill from Gilead that could help simplify care for some patients, the company announced Thursday.  The drug, marketed as Bixlenvo, is aimed at patients whose virus is already under control but who remain on complicated treatment regimens. It could also appeal to those who simply want…

Read More “FDA approves daily HIV pill from Gilead designed to simplify treatment for some patients” »

Health

AstraZeneca CEO says AI is reshaping drug development — and helping boost the odds of success

Posted on By Admin No Comments on AstraZeneca CEO says AI is reshaping drug development — and helping boost the odds of success

AstraZeneca CEO Pascal Soriot said artificial intelligence is helping drugmakers develop medicines faster and make smarter decisions throughout the research process. “The value of AI in our industry is productivity improvement,” Soriot said on CNBC’s “Mad Money” on Friday. “In the way you design a new medicine, a new drug, you can actually do it…

Read More “AstraZeneca CEO says AI is reshaping drug development — and helping boost the odds of success” »

Health

Trump policies, China’s biotech boom are ending Europe’s pharma powerhouse era

Posted on By Admin No Comments on Trump policies, China’s biotech boom are ending Europe’s pharma powerhouse era

Boxes of medication are seen on the shelves of the Keencare pharmacy, a member of the Green Light Group, on September 19, 2024 in London, England. Leon Neal | Getty Images News | Getty Images Once the go-to location for global drugmakers, Europe is now being squeezed by President Donald Trump’s aggressive trade and drug-pricing…

Read More “Trump policies, China’s biotech boom are ending Europe’s pharma powerhouse era” »

Health

Trump wants to slash U.S. drug prices with ‘most favored nation’ policy – here’s what to know 

Posted on By Admin No Comments on Trump wants to slash U.S. drug prices with ‘most favored nation’ policy – here’s what to know 

President Donald Trump, joined by National Institutes of Health (NIH) Director Jay Bhattacharya, speaks during a press conference in the Roosevelt Room of the White House on May 12, 2025, in Washington, DC. Andrew Harnik | Getty Images News | Getty Images President Donald Trump on Monday moved forward with a plan to lower U.S….

Read More “Trump wants to slash U.S. drug prices with ‘most favored nation’ policy – here’s what to know ” »

Health

These innovative biotech stocks have a good chance of breaking out in 2025

Posted on By Admin No Comments on These innovative biotech stocks have a good chance of breaking out in 2025

Trends may be shifting in favor of biotech stocks in 2025 after several years of poor performance, but it would still be wise to place your bets carefully on some of the most innovative names. “We’re still optimistic on the outlook for biotech,” said Stacey Sears, senior vice president and portfolio manager at Emerald Advisors,…

Read More “These innovative biotech stocks have a good chance of breaking out in 2025” »

Health